Pfizer Unit Pleads Guilty to Pay $491 Million Over Drug

Pfizer Unit Pleads Guilty to Pay $491 Million Over Drug

Peter Foley/Bloomberg

A Pfizer Inc. unit will pay $491 million and plead guilty to a federal charge tied to its illegal marketing of the kidney transplant drug Rapamune for use in other organ transplants, U.S. prosecutors said.